Update on allergy prevention and food introduction
October 22nd 2023In this Contemporary Pediatrics® interview, Scott Sicherer, MD, FAAP, discusses his session, "Feed the Baby! Essential Advice for Food Introduction and Allergy Prevention," presented at the 2023 2023 American Academy of Pediatrics National Conference & Exhibition.
Removing false labels of penicillin allergy from pediatric medical records
October 21st 2023At the 2023 American Academy of Pediatrics National Conference & Exhibition, Paul V. Williams, MD, FAAP, explains his session "Tell Me it Ain't So: Delabeling Penicillin Allergy," and how general pediatricians can make a difference by removing a false penicillin allergy label from a child's medical record.
Breaking down toddler formulas and the confusion associated with naming, labeling
October 21st 2023George J. Fuchs, III, MD, FAAP, explains how certain branding and labeling can lead parents to purchase toddler formula, though products are not nutritionally complete and lack FDA regulations present in infant formulas. This interview was conducted at the 2023 American Academy of Pediatrics National Conference & Exhibition in Washington DC.
Will FDA approved phentolamine ophthalmic solution 0.75% eye drops impact pediatric care?
September 28th 2023In this Contemporary Pediatrics® interview, Rupa Wong, MD, discusses the recent FDA approval of phentolamine ophthalmic solution 0.75% eye drops to treat pharmacologically-induced mydriasis, and how this could impact the treatment landscape for the pediatric population. [Editor's note: RYZUMVI was previously known as Nyxol, which is referenced in the interview.]
The current state of transgender reproductive care in the United States
September 14th 2023In this interview originally conducted by our sister publication Contemporary OB/GYN, Marci Bowers, MD, shares the biggest takeaways from her presentation on transgender reproductive care, presented at the 2023 Society of OB/GYN Hospitalists Annual Clinical Meeting in Chicago, Illinois.
Developing biomarkers for gut and neurological, cognitive functioning associations in children
September 7th 2023In this Contemporary Pediatrics interview, Rob Knight, PhD, discusses translating adult studies into children to determine gut microbiome biomarkers, and how they are associated with neurological and cognitive conditions.
Investigational Approaches for Treating T1D
Schafer Boeder, MD, and Egils K. Bogdanovics, MD, share approaches to prevention, preservation, and replacement therapies for the treatment of T1D.
How are gut microbiomes and pediatric neurological, cognitive conditions being linked?
August 28th 2023Rob Knight, PhD, Wolfe Endowed Chair in Microbiome Science at Rady Children's Hospital-San Diego, professor of pediatrics, UCSD, explains how links between gut microbiomes and cognitive and neurological conditions are being researched and what could be ahead for these associations in children.
Improving Access to Teplizumab and Future Treatments of T1D
Experts in endocrinology share challenges of patient access to type 1 diabetes treatment as well as resources to combat these challenges.
Long-Term Monitoring of Teplizumab in T1D
Expert endocrinologists discuss implementing long-term monitoring of patients being treated with teplizumab for type 1 diabetes and review the PROTECT study for patients who are newly diagnosed with T1D.
Why a correctly-fitting blood pressure cuff is important for children
August 22nd 2023In this Contemporary Pediatrics® interview, Tammy Brady, MD, PhD, explains how an incorrectly-fitting blood pressure cuff can lead to the wrong diagnosis in the pediatric population, and what tips to look for when shopping for cuffs currently on the market.
Potential links between neurological, cognitive conditions and gut microbiomes of children
August 17th 2023Watch as Rob Knight, PhD, Wolfe Endowed Chair in Microbiome Science at Rady Children's Hospital-San Diego, professor of pediatrics, UCSD, talks the gut microbiome and the potential associations with cognitive and neurological conditions in children, and why the topic is gaining interest and momentum.
Efficacy of Teplizumab in Clinical Trials
Egils K. Bogdanovics, MD, and the expert panel review the TN10 study data on the efficacy of teplizumab in delaying the progression of T1D, which led to the drug’s approval from the FDA.
What is new regarding pediatric orthopedic surgery?
August 9th 2023Jeanne Franzone, MD, orthopedic surgeon, surgical director, Osteogenesis Imperfecta Clinic, co-director, Prosthesis Clinic, Nemours Children’s Health, Delaware Valley, discusses recent technology, recommendations, and interactions with general health care providers in this Contemporary Pediatrics® interview.
Interpreting T1D Antibody Test Results
Egils K. Bogdanovics, MD, and Schafer Boeder, MD, discuss interpreting antibody test results for type 1 diabetes and provide recommendations for retesting for those who have a negative test or have only 1 antibody present.
Does asthma predispose higher risk of severe COVID-19?
August 7th 2023In this Contemporary Pediatrics® interview, Samir Gautam, MD, (Pulmonary, Critical Care and Sleep Medicine), Yale School of Medicine, senior author of a recently published study in the Journal of Allergy and Clinical Immunology: In Practice, reviews key findings of the study and explains how they relate to the pediatric population. Watch the full interview below.
Clinical Signs Leading to Diagnostic Testing for T1D
Expert endocrinologists discuss the clinical symptoms that prompt testing for T1D, as well the diagnostic testing tools that are available in clinical practice.
What skepticism is there regarding advanced atopic dermatitis treatment options?
July 28th 2023Peter Lio, MD, clinical assistant professor of dermatology and pediatrics at Northwestern University Feinberg School of Medicine in Chicago, Illinois, discusses the 2023 Society for Pediatric Dermatology Meeting held in Asheville, North Carolina, and what pearls to consider following the atopic dermatitis panel he took part in.